Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivors.

Saved in:
Bibliographic Details
Title: Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivors.
Authors: Yasin F; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, United States., Westvold SJ; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT, United States.; Department of Medicine (Internal Medicine), Yale School of Medicine, New Haven, CT, United States., Long JB; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT, United States.; Department of Medicine (Internal Medicine), Yale School of Medicine, New Haven, CT, United States., Hyslop T; Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States., Cecchini M; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, United States., Leeds I; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT, United States.; Department of Surgery (Colon and Rectal Surgery), Yale School of Medicine, New Haven, CT, United States., Silber A; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, United States., Wang SY; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT, United States.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States., Spees L; Lineberger Comprehensive Cancer Center (UNC-CH), Chapel Hill, NC, United States.; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, UNC-CH, Chapel Hill, NC, United States., Forman R; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, United States., Kwaramba T; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, United States., Taylor M; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, United States., Gross CP; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT, United States.; Department of Medicine (Internal Medicine), Yale School of Medicine, New Haven, CT, United States., Dinan MA; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT, United States.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States.
Source: JNCI cancer spectrum [JNCI Cancer Spectr] 2026 May 09; Vol. 10 (3).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2515-5091
DOI:10.1093/jncics/pkag002